1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. PI3K
  4. PI3K Inhibitors

PI3K Inhibitors

PI3Kα

PI3Kβ

PI3Kγ

PI3Kδ

PI3KC2α

PI3KC2β

PI3KC2γ

Vps34

PI3K

PI3KC3

p120γ

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PI3K Inhibitors, Activators & Modulators
Product Name PI3Kα PI3Kβ PI3Kγ PI3Kδ PI3KC2α PI3KC2β PI3KC2γ Vps34 PI3K PI3KC3 p120γ Purity
3-Methyladenine    
PtdIns3Kγ, IC50: 60 μM (Cell Assay)
       
Vps34, IC50: 25 μM (Cell Assay)
      ≥98.0%
LY294002
p110α, IC50: 0.5 μM
p110β, IC50: 0.97 μM
 
p110δ, IC50: 0.57 μM
              ≥98.0%
Alpelisib
p110α, IC50: 5 nM
p110α-H1047R, IC50: 4 nM
p110α-E545K, IC50: 4 nM
p110β, IC50: 1200 nM
p110γ, IC50: 250 nM
p110δ, IC50: 290 nM
              99.95%
Quercetin  
PI3Kβ, IC50: 5.4 μM
PI3Kγ, IC50: 3 μM
PI3Kδ, IC50: 2.4 μM
              ≥98.0%
Wortmannin                
PI3K, IC50: 3 nM
    ≥98.0%
AZ2
PI3Kα, pIC50: 5.1
PI3Kβ, pIC50: 4.5
PI3Kγ, pIC50: 9.3
PI3Kδ, pIC50: 6.6
              99.38%
ACT001                
PI3K
    98.85%
PKI-179 hydrochloride
PI3Kα, IC50: 8 nM
PI3Kβ, IC50: 24 nM
PI3Kγ, IC50: 74 nM
PI3Kδ, IC50: 77 nM
              98.11%
740 Y-P                
PI3K
    99.67%
Idelalisib
p110α, IC50: 820 nM
p110β, IC50: 565 nM
p110γ, IC50: 89 nM
p110δ, IC50: 2.5 nM
     
hVps34, IC50: 978 nM
      99.78%
Buparlisib
p110α, IC50: 52 nM
p110α-H1047R, IC50: 58 nM
p110α-E545K, IC50: 99 nM
p110β, IC50: 166 nM
p110γ, IC50: 262 nM
p110δ, IC50: 116 nM
     
Vps34, IC50: 2.4 μM
      99.90%
Dactolisib
p110α, IC50: 4 nM
p110α-H1047R, IC50: 4.6 nM
p110α-E545K, IC50: 5.7 nM
p110β, IC50: 75 nM
p110γ, IC50: 5 nM
p110δ, IC50: 7 nM
              99.94%
Eganelisib
PI3Kα, IC50: 3.2 μM
PI3Kβ, IC50: 3.5 μM
PI3Kγ, IC50: 16 nM
                ≥99.0%
Pictilisib
p110α, IC50: 3 nM
p110α-H1047R, IC50: 3 nM
p110α-E545K, IC50: 3 nM
p110β, IC50: 33 nM
p110γ, IC50: 75 nM
p110δ, IC50: 3 nM
              99.80%
Inavolisib
PI3Kα, IC50: 0.038 nM
                    98.94%
Copanlisib
PI3Kα, IC50: 0.5 nM
PI3Kβ, IC50: 3.7 nM
PI3Kγ, IC50: 6.4 nM
PI3Kδ, IC50: 0.7 nM
              99.50%
SAR405              
Vps34, IC50: 1.2 nM
Vps34, Kd: 1.5 nM
      99.13%
Duvelisib
p110α, IC50: 1602 nM
p110β, IC50: 85 nM
p110γ, IC50: 27.4 nM
p110δ, IC50: 2.5 nM
              ≥95.0%
YM-201636
p110α, IC50: 3.3 μM
                    98.01%
Taselisib
PI3Kα, Ki: 0.29 nM
PI3Kβ, Ki: 9.1 nM
PI3Kγ, Ki: 0.97 nM
PI3Kδ, Ki: 0.12 nM
              99.46%
Fimepinostat
PI3Kα, IC50: 19 nM
PI3Kβ, IC50: 54 nM
PI3Kγ, IC50: 311 nM
PI3Kδ, IC50: 39 nM
              99.95%
Recilisib                
PI3K
    ≥98.0%
PI-103
p110α, IC50: 8 nM
p110β, IC50: 88 nM
p110γ, IC50: 150 nM
p110δ, IC50: 48 nM
PI3KC2α, IC50: 1 μM
PI3KC2β, IC50: 26 nM
 
hsVPS34, IC50: 2.3 μM
      98.93%
Omipalisib
p110α, Ki: 0.019 nM
p110α-H1047R, Ki: 0.009 nM
p110α-E545K, Ki: 0.008 nM
p110α-E542K, Ki: 0.008 nM
p110β, Ki: 0.13 nM
p110γ, Ki: 0.06 nM
p110δ, Ki: 0.024 nM
              99.93%
Isorhamnetin                
PI3-K
    99.95%
PF-04691502
PI3Kα, Ki: 1.8 nM
PI3Kβ, Ki: 2.1 nM
PI3Kγ, Ki: 1.9 nM
PI3Kδ, Ki: 1.6 nM
              99.64%
Parsaclisib      
PI3Kδ, IC50: 1 nM
              99.31%
Autophinib              
Vps34, IC50: 19 nM
      99.55%
ZSTK474
PI3Kα, IC50: 16 nM
PI3Kβ, IC50: 44 nM
PI3Kγ, IC50: 49 nM
PI3Kδ, IC50: 4.6 nM
              99.71%
AZD 6482
PI3Kα, IC50: 136 nM
PI3Kβ, IC50: 0.69 nM
PI3Kγ, IC50: 47.8 nM
PI3Kδ, IC50: 13.6 nM
 
PI3K-C2β, IC50: 54.1 nM
 
hVps34, IC50: 3390 nM
      99.56%
α-Linolenic acid                
PI3K
    ≥99.0%
Umbralisib      
PI3Kδ, IC50: 22.2 nM
              ≥98.0%
Vps34-IN-1              
Vps34, IC50: 4 nM
      99.22%
GSK2636771  
PI3Kβ, Ki: 0.89 nM
PI3Kβ, IC50: 5.2 nM
                  99.86%
AZD8186
PI3Kα, IC50: 35 nM
PI3Kβ, IC50: 4 nM
PI3Kγ, IC50: 675 nM
PI3Kδ, IC50: 12 nM
              99.97%
PI3K-IN-1                
PI3K
    99.93%
AS-605240
PI3Kα, IC50: 60 nM
PI3Kβ, IC50: 270 nM
PI3Kγ, IC50: 8 nM
PI3Kγ, Ki: 7.8 nM
PI3Kδ, IC50: 300 nM
              ≥98.0%
Dactolisib Tosylate
p110α, IC50: 4 nM
p110α-H1047R, IC50: 4.6 nM
p110α-E545K, IC50: 5.7 nM
p110β, IC50: 75 nM
p110γ, IC50: 5 nM
p110δ, IC50: 7 nM
              99.88%
Samotolisib
PI3Kα, IC50: 6.07 nM
PI3Kβ, IC50: 77.6 nM
PI3Kγ, IC50: 23.8 nM
PI3Kδ, IC50: 38 nM
              99.42%
Copanlisib dihydrochloride
PI3Kα, IC50: 0.5 nM
PI3Kβ, IC50: 3.7 nM
PI3Kγ, IC50: 6.4 nM
PI3Kδ, IC50: 0.7 nM
              99.55%
TG100-115    
PI3Kγ, IC50: 83 nM
PI3Kδ, IC50: 235 nM
              99.31%
TGX-221  
p110β, IC50: 8.5 nM
 
p110δ, IC50: 211 nM
              ≥98.0%
Serabelisib
p110α, IC50: 15 nM
p110β, IC50: 4500 nM
p110γ, IC50: 1900 nM
p110δ, IC50: 13900 nM
              99.21%
PIK-75 hydrochloride
p110α, IC50: 5.8 nM
p110β, IC50: 1.3 μM
p110γ, IC50: 76 nM
p110δ, IC50: 510 nM
PI3KC2α, IC50: 10 μM
PI3KC2β, IC50: 1 μM
 
hsVPS34, IC50: 2.6 μM
      ≥98.0%
PKI-402
PI3Kα, IC50: 2 nM
PI3Kα-H1047R, IC50: 3 nM
PI3Kα-E545K, IC50: 3 nM
PI3Kβ, IC50: 7 nM
PI3Kγ, IC50: 16 nM
PI3Kδ, IC50: 14 nM
              99.79%
Vps34-PIK-III
PI(3)Kα, IC50: 3.96 μM
 
PI(3)Kγ, IC50: 3.04 μM
PI(3)Kδ, IC50: 1.2 μM
     
Vps34, IC50: 18 nM
      99.73%
PIK-93
p110α, IC50: 39 nM
p110β, IC50: 590 nM
p110γ, IC50: 16 nM
p110δ, IC50: 120 nM
PI3KC2α, IC50: 16 μM
PI3KC2β, IC50: 140 nM
 
hsVPS34, IC50: 320 nM
      ≥98.0%
Apitolisib
PI3Kα, IC50: 5 nM
PI3Kβ, IC50: 27 nM
PI3Kγ, IC50: 14 nM
PI3Kδ, IC50: 7 nM
              98.26%
BGT226 maleate
PI3Kα, IC50: 4 nM
PI3Kβ, IC50: 63 nM
PI3Kγ, IC50: 38 nM
                99.73%
Voxtalisib
p110α, IC50: 39 nM
p110β, IC50: 113 nM
p110γ, IC50: 9 nM
p110δ, IC50: 43 nM
              99.46%
CNX-1351
PI3Kα, IC50: 6.8 nM
PI3Kβ, IC50: 166 nM
PI3Kγ, IC50: 3020 nM
PI3Kδ, IC50: 240.3 nM
              ≥98.0%
Gedatolisib
PI3Kα, IC50: 0.4 nM
PI3Kα-H1047R, IC50: 0.6 nM
PI3Kα-E545K, IC50: 0.6 nM
PI3Kβ, IC50: 6 nM
PI3Kγ, IC50: 5.4 nM
PI3Kδ, IC50: 6 nM
              ≥98.0%
Bimiralisib
PI3Kα, IC50: 33 nM
PI3Kα-H1047R, IC50: 36 nM
PI3Kα-E545K, IC50: 136 nM
PI3Kα-E542K, IC50: 63 nM
PI3Kβ, IC50: 661 nM
PI3Kγ, IC50: 708 nM
PI3Kδ, IC50: 451 nM
     
Vps34, IC50: 6486 nM
      98.74%
GSK1059615
PI3Kα, IC50: 0.4 nM
PI3Kβ, IC50: 0.6 nM
PI3Kγ, IC50: 2 nM
PI3Kδ, IC50: 5 nM
              ≥99.0%
CH5132799
PI3Kα, IC50: 14 nM
PI3Kα-H1047R, IC50: 5.6 nM
PI3Kα-E545K, IC50: 6.7 nM
PI3Kα-E542K, IC50: 6.7 nM
PI3Kβ, IC50: 120 nM
PI3Kγ, IC50: 36 nM
PI3Kδ, IC50: 500 nM
 
PI3KC2β, IC50: 5.3 μM
          98.81%
PI4KIIIbeta-IN-9
PI3Kα, IC50: 2 μM
 
PI3Kγ, IC50: 1046 nM
PI3Kδ, IC50: 152 nM
   
PI3KC2γ, IC50: 1 μM
        99.01%
Sonolisib
p110α, IC50: 0.1 nM
   
p110δ, IC50: 2.9 nM
           
p120γ, IC50: 1 nM
≥99.0%
Sophocarpine                
PI3K
    ≥98.0%
1,3-Dicaffeoylquinic acid                
PI3K
    98.85%
VS-5584
PI3Kα, IC50: 16 nM
PI3Kβ, IC50: 68 nM
PI3Kγ, IC50: 25 nM
PI3Kδ, IC50: 42 nM
     
Vps34, IC50: 7470 nM
      ≥95.0%
PIK-90
p110α, IC50: 11 nM
p110β, IC50: 350 nM
p110γ, IC50: 18 nM
p110δ, IC50: 58 nM
PI3KC2α, IC50: 47 nM
PI3KC2β, IC50: 64 nM
 
hsVPS34, IC50: 830 nM
      99.70%
Nemiralisib
PI3Kα, pIC50: 5.3
PI3Kβ, pIC50: 5.8
PI3Kγ, pIC50: 5.2
PI3Kδ, pKi: 9.9
              98.85%
GDC-0326
PI3Kα, Ki: 0.2 nM
PI3Kβ, Ki: 26.6 nM
PI3Kγ, Ki: 10.2 nM
PI3Kδ, Ki: 4 nM
              99.70%
Quercetin dihydrate  
PI3Kβ, IC50: 5.4 μM
PI3Kγ, IC50: 2.4 μM
PI3Kδ, IC50: 3.0 μM
              ≥97.0%
CGS 15943    
p110γ, IC50: 1.1 μM
p110δ, IC50: 8.47 μM
              ≥99.0%
Linperlisib      
PI3Kδ, IC50: 6.4 nM
              99.80%
Esculetin                
PI3K
    ≥98.0%
AZD-8835
PI3Kα, IC50: 6.2 nM
PI3Kα-E545K, IC50: 6 nM
PI3Kα-H1047R, IC50: 5.8 nM
PI3Kβ, IC50: 431 nM
PI3Kγ, IC50: 90 nM
PI3Kδ, IC50: 5.7 nM
              98.63%
Leniolisib
PI3Kα, IC50: 280 nM
PI3Kβ, IC50: 480 nM
PI3Kγ, IC50: 2.57 μM
PI3Kδ, IC50: 11 nM
              99.25%
AZD3458
PI3Kα, pIC50: 5.1
PI3Kβ, pIC50: 4.5
PI3Kγ, pIC50: 9.1
PI3Kδ, pIC50: 6.5
PI3KC2α, pIC50: 5
PI3KC2β, pIC50: 7.5
PI3KC2γ, pIC50: 5.5
   
PI3KC3, pIC50: 5.1
  99.82%
KP372-1                
PI3-K
    99.52%
AMG 511
PI3Kα, Ki: 4 nM
PI3Kβ, Ki: 6 nM
PI3Kγ, Ki: 1 nM
PI3Kδ, Ki: 2 nM
              98.81%
GNE-317                
PI3K
    99.31%
Pilaralisib
PI3Kα, IC50: 39 nM
PI3Kβ, IC50: 383 nM
PI3Kγ, IC50: 23 nM
PI3Kδ, IC50: 36 nM
     
Vps34, IC50: 6974 nM
      99.57%
PQR530
PI3Kα, Kd: 0.84 nM
PI3Kβ, Kd: 6.1 nM
PI3Kγ, Kd: 10 nM
PI3Kδ, Kd: 11 nM
 
PI3KC2β, Kd: 100 nM
          99.93%
Pictilisib dimethanesulfonate
p110α, IC50: 3 nM
p110α-H1047R, IC50: 3 nM
p110α-E545K, IC50: 3 nM
p110β, IC50: 33 nM
p110γ, IC50: 75 nM
p110δ, IC50: 3 nM
              99.31%
IC-87114  
PI3Kβ, IC50: 75 μM
PI3Kγ, IC50: 29 μM
PI3Kδ, IC50: 0.5 μM
              98.97%
AS-252424
PI3Kα, IC50: 935 nM
PI3Kβ, IC50: 20 μM
PI3Kγ, IC50: 30 nM
PI3Kδ, IC50: 20 μM
              99.31%
Tenalisib    
PI3Kγ, IC50: 33 nM
PI3Kδ, IC50: 25 nM
              98.94%
SF2523
PI3Kα, IC50: 34 nM
 
PI3Kγ, IC50: 158 nM
                97.32%
AMG319
PI3Kα, IC50: 33 μM
PI3Kβ, IC50: 2.7 μM
PI3Kγ, IC50: 850 nM
PI3Kδ, IC50: 18 nM
              98.27%
HS-173
PI3Kα, IC50: 0.8 nM
                    ≥98.0%
Seletalisib      
PI3Kδ, IC50: 12 nM
              98.50%
SAR-260301
PI3Kα, IC50: 1539 nM
PI3Kβ, IC50: 23 nM
PI3Kγ, IC50: 10000 nM
PI3Kδ, IC50: 468 nM
   
PI3KC2γ, IC50: 3812 nM
Vps34, IC50: 183 nM
      99.37%
A66
p110α, IC50: 32 nM
p110α E545K, IC50: 30 nM
p110α H1047R, IC50: 43 nM
 
p110γ, IC50: 3480 nM
   
PI3K-C2β, IC50: 462 nM
          99.26%
IITZ-01    
PI3Kγ, IC50: 2.62 μM
                99.05%
hSMG-1 inhibitor 11j
PI3Kα, IC50: 92 nM
 
PI3Kγ, IC50: 60 nM
                99.81%
Arnicolide D                
PI3K
    ≥99.0%
Duvelisib (R enantiomer)                
PI3K
   
PI3K/mTOR Inhibitor-2
PI3Kα, IC50: 3.4 nM
PI3Kβ, IC50: 34 nM
PI3Kγ, IC50: 1 nM
PI3Kδ, IC50: 16 nM
              99.45%
PI-103 Hydrochloride
p110α, IC50: 2 nM
p110β, IC50: 3 nM
p110γ, IC50: 15 nM
p110δ, IC50: 3 nM
              98.06%
Buparlisib Hydrochloride
p110α, IC50: 52 nM
p110α-H1047R, IC50: 58 nM
p110α-E545K, IC50: 99 nM
p110β, IC50: 166 nM
p110γ, IC50: 262 nM
p110δ, IC50: 116 nM
     
Vps34, IC50: 2.4 μM
      99.79%
MSC2360844
PI3Kα, IC50: 18500 nM
PI3Kβ, IC50: 2850 nM
 
PI3Kδ, IC50: 145 nM
              99.96%
SRX3207
PI3Kα, IC50: 861 nM
 
PI3Kγ, IC50: 11100 nM
PI3Kδ, IC50: 1280 nM
              98.92%
Acalisib
p110α, IC50: 5441 nM
p110β, IC50: 3377 nM
p110γ, IC50: 1389 nM
p110δ, IC50: 12.7 nM
     
hVps34, IC50: 12682 nM
      99.98%
PI-3065
p110α, IC50: 910 nM
p110β, IC50: 600 nM
 
p110δ, IC50: 5 nM
              99.82%
PF-4989216
PI3Kα, Ki: 0.6 nM
                    99.69%
GNE-477
PI3Kα, IC50: 4 nM
                    98.70%
Vps34-IN-2              
Vps34, IC50: 2 nM
      99.74%
Pilaralisib analogue
PI3K-alpha
                    99.67%
BAY1082439
PI3Kα
PI3Kβ
 
PI3Kδ
              99.46%
MTX-211                
PI3K
    ≥98.0%
CAY10505    
PI3Kγ, IC50: 30 nM (Neurons)
                99.79%
PF-04979064
PI3Kα, Ki: 0.13 nM
 
PI3Kγ, Ki: 0.111 nM
PI3Kδ, Ki: 0.122 nM
              99.83%
TG 100713
PI3Kα, IC50: 165 nM
PI3Kβ, IC50: 215 nM
PI3Kγ, IC50: 50 nM
PI3Kδ, IC50: 24 nM
              99.49%
PI-828
p110α, IC50: 173 nM
                    ≥98.0%
Glaucocalyxin A                
PI3K
    99.38%
Zandelisib      
PI3Kδ, IC50: 3.5 nM
              98.79%
NSC781406
PI3Kα, IC50: 2 nM
PI3Kβ, IC50: 9.4 nM
PI3Kγ, IC50: 2.7 nM
PI3Kδ, IC50: 14 nM
              99.91%
Umbralisib hydrochloride      
PI3Kδ, IC50: 22.2 nM
              98.98%
PI3Kα-IN-4
PI3Kα, IC50: 1.8 nM
                    99.83%
IPI-3063
p110α, IC50: 1170 nM
p110β, IC50: 1508 nM
p110γ, IC50: 2187 nM
p110δ, IC50: 2.5 nM
              98.80%
AS-604850
PI3Kα, IC50: 4.5 μM
 
PI3Kγ, IC50: 0.25 μM
PI3Kγ, Ki: 0.18 μM
                99.91%
TASP0415914    
PI3Kγ, IC50: 29 nM
                99.37%
Polygalasaponin F                
PI3K
    ≥99.0%
ETP-46321
p110α, Ki: 2.3 nM
PI3Kα-H1047R, Ki: 2.33 nM
PI3Kα-E545K, Ki: 1.77 nM
PI3Kα-E542K, Ki: 1.89 nM
p110β, Ki: 170 nM
p110γ, Ki: 179 nM
p110δ, Ki: 14.2 nM
              99.65%
(S)-PI3Kα-IN-4
PI3Kα, IC50: 2.3 nM
                    99.79%
CZC24832  
PI3Kβ, IC50: 1.1 μM
PI3Kγ, IC50: 27 nM
PI3Kδ, IC50: 8.194 μM
              99.46%
BEBT-908
PI3Kα, IC50: 0.1 μM
                    99.14%
Hederacolchiside A1                
PI3K
    ≥99.0%
NVS-PI3-4    
PI3Kγ
                99.74%
AS-041164
PI3Kα, IC50: 240 nM
PI3Kβ, IC50: 1.4 μM
PI3Kγ, IC50: 70 nM
PI3Kδ, IC50: 1.7 μM
              ≥98.0%
Brevianamide F
PI3Kα, IC50: 4.8 μM
                    99.49%
GNE-493
PI3Kα, IC50: 3.4 nM
PI3Kβ, IC50: 12 nM
PI3Kγ, IC50: 16 nM
PI3Kδ, IC50: 16 nM
              98.33%
PIK-294
p110α, IC50: 10 μM
p110β, IC50: 490 nM
p110γ, IC50: 160 nM
p110δ, IC50: 10 nM
              99.67%
Parsaclisib hydrochloride      
PI3Kδ, IC50: 1 nM
              98.74%
PF-06843195
PI3Kα, IC50: 18 nM (in Rat1 fibroblasts)
PI3Kα, Ki: 0.018 nM
PI3Kβ, IC50: 360 nM (in Rat1 fibroblasts)
 
PI3Kδ, IC50: 160 nM (in Rat1 fibroblasts)
PI3Kδ, Ki: 0.28 nM
             
CYH33
PI3Kα, IC50: 5.9 nM
PI3Kβ, IC50: 598 nM
PI3Kγ, IC50: 225 nM
PI3Kδ, IC50: 78.7 nM
             
Sophocarpine monohydrate                
PI3K
    ≥99.0%
KU-0060648
PI3Kα, IC50: 4 nM
PI3Kβ, IC50: 0.5 nM
PI3Kγ, IC50: 0.594 μM
PI3Kδ, IC50: 0.1 nM
              99.39%
PKI-179
PI3Kα, IC50: 8 nM
PI3Kβ, IC50: 24 nM
PI3Kγ, IC50: 74 nM
PI3Kδ, IC50: 77 nM
              ≥98.0%
PIK-293
PI3Kα, IC50: 100 μM
PI3Kβ, IC50: 10 μM
PI3Kγ, IC50: 25 μM
PI3Kδ, IC50: 0.24 μM
              98.55%
WYE-687
PI3K alpha, IC50: 81 nM
 
PI3K gamma, IC50: 3.11 μM
                97.17%
NVP-QAV-572                
PI3K, IC50: 10 nM
    98.05%
CAL-130 Hydrochloride
p110α, IC50: 115 nM
p110β, IC50: 56 nM
p110γ, IC50: 6.1 nM
p110δ, IC50: 1.3 nM
              99.88%
GS-9901      
PI3Kδ, IC50: 1 nM
             
BGT226
PI3Kα, IC50: 4 nM
PI3Kβ, IC50: 63 nM
PI3Kγ, IC50: 38 nM
               
CYH33 methanesulfonate
PI3Kα, IC50: 5.9 nM
PI3Kβ, IC50: 598 nM
PI3Kγ, IC50: 225 nM
PI3Kδ, IC50: 78.7 nM
             
IHMT-PI3Kδ-372      
PI3Kδ, IC50: 14 nM
             
PI3K-IN-6
PI3Kα, IC50: 850 nM
PI3Kβ, IC50: 7.8 nM
 
PI3Kδ, IC50: 5.3 nM
             
PI3Kδ-IN-8
PI3Kα, IC50: 377.2 nM
PI3Kβ, IC50: 241.6 nM
PI3Kγ, IC50: 17.9 nM
PI3Kδ, IC50: 3.3 nM
             
FD223
PI3Kα, IC50: 51 nM
PI3Kβ, IC50: 29 nM
PI3Kγ, IC50: 37 nM
PI3Kδ, IC50: 1 nM
              98.68%
PI3Kγ inhibitor 2    
PI3Kγ, Ki: 4 nM
               
PI3Kdelta inhibitor 1      
PI3Kδ, IC50: 1.3 nM
             
PARP/PI3K-IN-1
PI3Kα, pIC50: 8.25
PI3Kβ, pIC50: 6.54
PI3Kγ, pIC50: 6.08
PI3Kδ, pIC50: 8.13
             
LAS191954      
PI3Kδ, IC50: 2.6 nM
             
PI3K-IN-9      
PI3Kδ
             
CHMFL-PI3KD-317
PI3Kα, IC50: 62.6 nM
PI3Kβ, IC50: 284 nM
PI3Kγ, IC50: 202.7 nM
PI3Kδ, IC50: 6 nM
 
PIK3C2B, IC50: 882.3 nM
 
Vps34, IC50: 1801.7 nM
     
AZD8154    
PI3Kγ
               
PI3K/HDAC-IN-1
PI3Kα, IC50: 42 nM
PI3Kβ, IC50: 101 nM
PI3Kγ, IC50: 67 nM
PI3Kδ, IC50: 8.1 nM
             
PI3Kγ inhibitor 4
PI3Kα, IC50: 300 nM
 
PI3Kγ, IC50: 40 nM
               
MSC2360844 hemifumarate      
PI3Kδ, IC50: 145 nM
              99.95%
PI3K-IN-2
PI3Kα, IC50: 13 nM
PI3Kβ, IC50: 7.1 nM
PI3Kγ, IC50: 8.6 nM
PI3Kδ, IC50: 190 nM
             
PI3K/mTOR Inhibitor-1
PI3Kα, IC50: 20 nM
PI3Kβ, IC50: 376 nM
PI3Kγ, IC50: 204 nM
PI3Kδ, IC50: 46 nM
             
PI3K-IN-22
PI3Kα, IC50: 0.9 nM
                   
PI3K/mTOR Inhibitor-3                
PI3K
   
WYE-687 dihydrochloride
PI3K alpha, IC50: 81 nM
 
PI3K gamma, IC50: 3.11 μM
                ≥98.0%
GSK2292767      
PI3Kδ, pIC50: 10.1
             
Umbralisib R-enantiomer      
PI3Kδ
              99.52%
PIK-75
p110α, IC50: 5.8 nM
p110β, IC50: 1.3 μM
p110γ, IC50: 76 nM
p110δ, IC50: 510 nM
PI3KC2α, IC50: 10 μM
PI3KC2β, IC50: 1 μM
 
hsVPS34, IC50: 2.6 μM
     
PI3K-IN-20                
PI3K
   
hSMG-1 inhibitor 11e
PI3Kα, IC50: 61 nM
 
PI3Kγ, IC50: 92 nM
                99.18%
PI3K-IN-10                
PI3K
   
NVP-BAG956
PI3Kα, IC50: 56 nM
PI3Kβ, IC50: 446 nM
PI3Kγ, IC50: 117 nM
PI3Kδ, IC50: 35 nM
             
PI3Kγ inhibitor 1
PI3Kα, IC50: 10 μM
PI3Kβ, IC50: 10 μM
PI3Kγ, IC50: 100 nM
PI3Kδ, IC50: 100 nM
             
CAL-130 Racemate      
PI3Kδ
             
ON 146040
PI3Kα, IC50: 14 nM
PI3Kβ, IC50: 3 μM
PI3Kγ, IC50: 1 μM
PI3Kδ, IC50: 20 nM
             
CAL-130
p110α, IC50: 115 nM
p110β, IC50: 56 nM
p110γ, IC50: 6.1 nM
p110δ, IC50: 1.3 nM
             
PI3kδ inhibitor 1      
PI3Kδ, IC50: 3.8 nM
             
PI3Kα/mTOR-IN-1
PI3Kα, Ki: 12.5 nM
PI3Kα, IC50: 7 nM (Cell Assay)